AAAAAA

   
Results: 1-6 |
Results: 6

Authors: Ajani, AE Maruff, P Warren, R Eccleston, D Dick, R Maclsaac, A Rowe, M Lefkovits, J
Citation: Ae. Ajani et al., Impact of early percutaneous coronary intervention on short- and long-termoutcomes in patients with cardiogenic shock after acute myocardial infarction, AM J CARD, 87(5), 2001, pp. 633-635

Authors: Abenhaim, HA Eisenberg, MJ Schechter, D Lefkovits, J Goudreau, E Deligonul, U Mak, KH Duerr, R Del Core, M Huynh, T Smilovitch, M Sedlis, S Brown, DL Brieger, D
Citation: Ha. Abenhaim et al., Comparison of six-month outcomes of percutaneous transluminal coronary angioplasty in patients >= 75 with those < 75 years of age (The ROSETTA Registry), AM J CARD, 87(12), 2001, pp. 1392-1395

Authors: Huynh, T Eisenberg, M Deligonul, U Tsang, J Okrainec, K Schechter, D Lefkovits, J Mak, KH Brown, DL Brieger, D
Citation: T. Huynh et al., Coronary stenting in diabetic patients: Results from the ROSETTA registry, AM HEART J, 142(6), 2001, pp. 960-964

Authors: Eisenberg, MJ Schechter, D Lefkovits, J Goudreau, E Deligonul, U Mak, KH Del Core, M Duerr, R Garzon, PM Huynh, T Smilovitch, M Sedlis, S Brown, DL Brieger, D Pilote, L
Citation: Mj. Eisenberg et al., Use of routine functional resting after percutaneous transluminal coronaryangioplasty: Results from the ROSETTA Registry, AM HEART J, 141(5), 2001, pp. 837-846

Authors: Lefkovits, J Topol, EJ
Citation: J. Lefkovits et Ej. Topol, Intravenous glycoprotein IIb/IIIa receptor inhibitor agents in ischemic heart disease, ACUTE CORONARY SYNDROMES, SECOND EDITION, 2001, pp. 419-452

Authors: Topol, EJ Ohman, EM Barnathan, E Califf, RM Lee, KL Lincoff, AM Ohman, EM Scherer, J Scott, R Sketch, MH Topol, EJ Weisman, HF Cantor, W Evans, B Harris, J Kirby, J Miller, J Minshall, D Oliverio, RM Stebbins, AL Webb, L Wittlief, J Topol, EJ Lincoff, AM Moliterno, DJ Ivanc, T Barnathan, E Damaraju, L Hadley, K Kukulewicz, L Scherer, J Scott, R Schwarz, R Waller, M Weisman, H Lincoff, AM Bachinsky, WB Bell, C Butler, JF David, SW Gibbs, K Sakhaii, M Hanovich, G Herrmann, H Hillegass, W Kereiakes, DJ Kiernan, J McGrew, FA Miklin, JS Miller, L Sketch, MH Riba, A Schreiber, TL Smalling, RW Talley, JD Worley, S Bates, ER Hearne, S Morris, DC Priest, MF Pelikan, P Seals, AA Smith, JE Bach, RG Laufer, N Phillips, PS McClure, R Navetta, FI Bhoopalam, V Aylward, PE Ardissino, D Betriu, A della Misericordi, OSM Morocutti, G Muller, DWM Grinfeld, L Cagide, A Bode, C Forycki, F Lefkovits, J Steg, G Macaya, C Schultheiss, HP Eberli, F
Citation: Ej. Topol et al., Trial of abciximab with and without low-dose reteplase for acute myocardial infarction, CIRCULATION, 101(24), 2000, pp. 2788-2794
Risultati: 1-6 |